Bone Health Assessment in Men on Androgen Deprivation Therapy for Prostate Cancer: A Nurse Practitioner-Led Quality Improvement Protocol

Identification: unj_nd19_02
Issue: November-December 2019
Volume: Volume 39 Number 6
Credits (Post Test and/or Evaluation Required)
Available until 12/31/2021
  • 1.30 - CH


Contact hours available until 12/31/2021.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).

The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN-BC, SUNA Education Director.

Learning Outcome:
After completing this learning activity, the learner will be able to discuss how a Nurse Practitioner-led QI protocol facilitated consistency in providing evidence-based practice related to bone health screening, education and treatment for men with prostate cancer on ADT.

Learner Engagement Activity:
This article emphasizes the increased risk for fracture in men who are being treated with ADT for prostate cancer. Visit the NCCN website at to review the guidelines for prostate cancer.


Credits Available

Expired On: Dec 31, 2021

You must be logged in and own this product in order to post comments.

Louise Kester
9/10/20 2:00 pm

I read this article. Found the information relevant to our practice. As a staff nurse I given a fair amount of ADT injections to our prostate cancer patient. Spoke with one of our lead MD's who does a lot of CA Tx. We discussed bone loss and treatment, he asked me to encourage the pt's to use calcium and vitamin D as the providers recommend. This is a real issue with this treatment mostly in the older population that is a bone loss, fall rise group.